<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="15" ids="28087">Glycogen</z:chebi> <z:e sem="disease" ids="C0267971" disease_type="Disease or Syndrome" abbrv="">storage disease</z:e> type II (also called <z:e sem="disease" ids="C0017921" disease_type="Disease or Syndrome" abbrv="AMD">Pompe's disease</z:e> or <z:e sem="disease" ids="C0017921" disease_type="Disease or Syndrome" abbrv="AMD">acid maltase deficiency</z:e>) is an <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorder</z:e> which causes an accumulation of <z:chebi fb="15" ids="28087">glycogen</z:chebi> in the lysosomes due to deficiency of the lysosomal acid alpha-glucosidase enzyme </plain></SENT>
<SENT sid="1" pm="."><plain>It is the only <z:chebi fb="15" ids="28087">glycogen</z:chebi> <z:e sem="disease" ids="C0267971" disease_type="Disease or Syndrome" abbrv="">storage disease</z:e> with a defect in lysosomal metabolism, and the first <z:chebi fb="15" ids="28087">glycogen</z:chebi> <z:e sem="disease" ids="C0267971" disease_type="Disease or Syndrome" abbrv="">storage disease</z:e> to be identified in 1932 </plain></SENT>
<SENT sid="2" pm="."><plain>The build-up of <z:chebi fb="15" ids="28087">glycogen</z:chebi> causes <z:hpo ids='HP_0003323'>progressive muscle weakness</z:hpo> (<z:hpo ids='HP_0003198'>myopathy</z:hpo>) throughout the body and affects various body tissues, particularly in the heart, skeletal muscles, liver, and <z:mp ids='MP_0008912'>nervous</z:mp> system </plain></SENT>
<SENT sid="3" pm="."><plain>We are presenting two cases of infantile form of <z:e sem="disease" ids="C0017921" disease_type="Disease or Syndrome" abbrv="AMD">Pompe's disease</z:e> with secondary <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> (<z:chebi fb="1" ids="17361">CMP</z:chebi>) </plain></SENT>
<SENT sid="4" pm="."><plain>The first case was a 1-year-old female child who presented with Ross Class III <z:hpo ids='HP_0001635'>heart failure</z:hpo> (HF) of 3 months duration </plain></SENT>
<SENT sid="5" pm="."><plain>Echocardiography (ECHO) showed concentric left ventricular (LV) <z:mpath ids='MPATH_159'>hypertrophy</z:mpath>, with the posterobasal segment more hypertrophic than the inter-ventricular septum and moderate <z:hpo ids='HP_0001698'>pericardial effusion</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The second case was a 2-month-old male child who presented with Ross Class II HF </plain></SENT>
<SENT sid="7" pm="."><plain>His ECHO showed eccentric <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> of the posterobasal left ventricle, with thickening of the mitral valve leaflets and the chordae with Grade I <z:hpo ids='HP_0001653'>mitral regurgitation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>) </plain></SENT>
<SENT sid="8" pm="."><plain>Both children were diagnosed to have <z:e sem="disease" ids="C0017921" disease_type="Disease or Syndrome" abbrv="AMD">Pompe's disease</z:e> by blood alpha-glucosidase assay </plain></SENT>
</text></document>